181289-33-8Relevant articles and documents
Synthesis and characterization of impurities of an anticonvulsant drug, Pregabalin
Sripathi, Somaiah,Somesetti, Narender Rao,Veeramalla, Raju,Challa, Nageswar Rao,Peddi, Srinivasa Rao,Karnati, Venugopal Reddy
, p. 266 - 275 (2010)
During the process development of Pregabalin 1, a known anticonvulsant drug, six potential impurities were identified in the final crude material ranging from 0.01 to 0.15% by LCMS. All six impurities were subsequently synthesized and characterized by IR, MS and NMR spectral data. Four of the six related substances are known as 4-isobutylpyrrolidin-2-one 6, 3-isobutylglutaric acid 2, (R)-(-)-3-carbamoylmethyl-5-methylhexanoic acid 5 and (R)-(-)-3-aminomethyl-5-methylhexanoic acid 8, whilst (S)-3-aminomethyl-5- methylhexanoic acid isobutyl ester 9 and (S)-3-aminomethyl-5-methylhexanoic acid isopropyl ester 10 are new compounds reported for the first time in our process. The present work describes the formation, synthesis and characterization of these impurities. ARKAT USA, Inc.
Method for preparing pregabalin intermediate
-
Paragraph 0023-0042, (2021/03/06)
The invention discloses a method for preparing a pregabalin intermediate, namely, R-3-isobutyl glutaric acid monoamide. The method comprises the following steps: (1) adding 3-isobutyl glutaric acid monoamide into a system of chloroform and an alcohol solv
AN IMPROVED PROCESS FOR THE PREPARATION OF PREGABALIN
-
, (2019/10/29)
The present invention relates to an improved process for the preparation of 3-isobutyl glutaric acid compound of formula-1 which is used as the key intermediate in the preparation of Pregabalin compound of formula-A. The present invention also relates to an improved process for the preparation of (S)-3-(aminomethyl)-5-methylhexanoic acid compound of formula-A.